Nanoparticles deliver medicine to brain tissue for neurodegenerative disorders

Summary: New research from Michigan State University reveals nanoparticles can deliver medicine to brain tissue through the digestive system, benefiting patients with neurodegenerative disorders like MS, ALS, and PD. Published in Nature Communications, the study emphasizes the importance of standardized protein corona analysis for clinical applications. CNM-Au8, developed by Clene Nanomedicine, Inc., utilizes gold nanocrystals to treat neurodegenerative diseases effectively. This innovative method enhances the nanocrystals' ability to cross the blood-brain barrier.

Full article